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Abstract 
Solitary fibrous tumor (SFT) is a rare spindle cell neoplasm that usually develops in the pleura and peritoneum. The 
head and neck region is involved in only 6% of the cases.  Involvement of the parotid gland is a rare phenomenon, 
with only 24 cases reported in the literature. The aim of this study is to report an additional case of SFT affecting 
the parotid gland, and to review the literature on previously reported cases. The patient was a 42-year-old male with 
a 4-cm, fibro-elastic, movable, painless nodule in the inferior lobe of the parotid gland. The lesion was surgically 
excised and, following histopathological and immunohistochemical analysis, a diagnosis of SFT was rendered. The 
patient has been followed-up for ten months, with no signs of recurrence. Clinical, histopathological, immunohis-
tochemical and treatment aspects of the tumor are discussed.
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Introduction
Solitary fibrous tumor (SFT) is a rare spindle cell neo-
plasm that usually develops in the pleura and peritoneum 
(1). Although the lesion has also been described in other 
tissues not associated with serosal surfaces, the head and 
neck is involved in only 6% of the cases (2). Involve-
ment of the parotid gland is even a rarer phenomenon, 
with only 24 cases reported in the literature (3-5). The 
aim of this study is to report an additional case of SFT 
affecting the parotid gland, and to review the literature 
on previously reported cases. Clinical, histopathologi-
cal, immunohistochemical and treatment aspects of the 
tumor are discussed. 
Case Report
A 42-year-old male was seen with a nodule on his left 
parotid, with evolution of two months. Medical history 
was non-contributory. Extra-oral clinical examination 
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showed a 4-cm, fibro-elastic, movable, painless nodule 
in the inferior lobe of the parotid gland. With the clinical 
impression of a benign salivary gland tumor, the patient 
was submitted to left partial parotidectomy, with conser-
vation of the facial nerve, and dismissed 12 hours after 
surgery. Gross examination showed a 7.5 x 4.5 x 3.0 cm 
parotid gland, weighing 25g with a soft, well-defined, 
4.0 x 3.0 x 3.0 cm mass. The lesion was light-brown 
and hemorrhagic. Microscopic examination showed a 
well-circumscribed, lobulated proliferation of spindle 
cells. The lesion was heterogenous without a defined ar-
chitectural pattern, with alternating areas of hyper- and 
hypocellularity (Fig. 1). Intercellular collagen deposi-
tion (Fig. 1) and multifocal cystic degeneration were 
observed. The lesion was highly vascular, with heman-
gioperycytoma-like areas (Fig. 1). Hyalinization of ves-
sels was also noted (Fig. 1). Atypical mitoses, necrosis, 
pleomorphism or other signs of malignancy were absent. 
Immunohistochemical analysis showed the lesional cells 
were positive for CD34, CD99 and bcl-2 (Fig. 2), and 
negative for CAM-5.2, SMA and S100. Based on histo-
pathological and immunohistochemical results, the final 
diagnosis was solitary fibrous tumor.  The patient has 
been followed-up for ten months, with no signs of re-
currence.
Fig. 1. Histopathological findings. a) A heterogenous proliferation without a defined architectural pattern and alternating areas of 
hyper- and hypocellularity was observed; b) Intercellular collagen deposition was noted within the spindle cell proliferation; c) He-
mangioperycytoma-like area of the tumor; d) Hyalinization of vessels was also noted.
Fig. 2. Immunohistochemical positivity was noted for bcl-2, CD34 
and CD99.
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Grossly, parotid SFT present as firm, white-tan or gray, 
partially or fully encapsulated, well-circumscribed le-
sions (3). Microscopically, round to spindled cells, 
arranged in fascicular, storiform or fibrosarcoma-like 
patterns, are observed. Cells have round to oval, centra-
lly placed nuclei, with open, vesicular nuclear chromatin 
distribution. The stroma shows numerous medium-sized 
ramifying vessels, which may have thickened or hyali-
nized walls. There are a variety of histologic features 
accepted as diagnostic criteria, including alternating hy-
percellular and hypocellular to fibrous areas. In addition, 
a number of additional features can be seen, including 
stromal myxoid change, inflammatory cells, especially 
mast cells, and isolated multinucleated stromal tumor 
giant cells (3). Due to SFT’s wide spectrum of histologic 
features, there is a broad differential diagnosis. There is 
a significant morphologic overlap between SFT and he-
mangiopericytoma (HPC), and experts have questioned 
the concept of the latter. Indeed, Gengler and Guillou (9) 
suggested that most tumors that had been diagnosed HPC 
in the past were not truly of pericytic origin, but instead 
a cellular variant of SFT. Lesions to be considered in 
the differential diagnosis include cellular pleomorphic 
adenoma, myoepithelioma, schwannoma, neurofibroma, 
benign fibrous histiocytoma, nodular fasciitis, fibroma-
tosis, myofibroblastoma, meningioma, fibrosarcoma, 
spindle cell squamous cell carcinoma, spindle cell mela-
noma, Kaposi sarcoma and monophasic synovial sarco-
ma (3).  Thus, immunohistochemistry is often required 
to reach the final diagnosis. CD34 is the most important 
and sensitive marker for the diagnosis of SFT, although 
it may not be positive in all cases. Virtually all cases of 
SFT stain with vimentin and the vast majority is positi-
ve for CD34, bcl-2 and CD99 (3).  In previous reports, 
13/13, 19/21, 8/9 and 5/6 parotid SFT were positive for 
vimentin, CD34, bcl-2 and CD99, respectively. Parotid 
SFT stained negatively for S100, SMA and CAM 5.2 in 
16/16, 14/14 and 7/7 previously described cases, respec-
tively (3-5).
SFT are generally treated by complete local surgi-
cal excision. Because SFTs are often highly vascular, 
profuse bleeding is possible when resecting the tumor 
(10). Some authors have reported favorable results with 
postoperative chemotherapy and radiotherapy after sur-
gery in cases whith incomplete resection (11). Despite 
a short follow-up period in previously reported cases, 
recurrence was not a common finding (3). Nonetheless, 
long-term follow-up with clinical and imaging exami-
nations (ultrasonography and/or computed tomography) 
for at least 3 to 5 years has been recommended (5).
Of the 25 cases previously reported, three were diagno-
sed as malignant SFT. Grossly, two tumors were well-
circumscribed (3). Tumors possessing histologically ma-
lignant features such as high cellularity, pleomorphism, 
necrosis, high mitotic rate, and/or infiltrative margins 
Discussion
SFT is exceptionally rare in the parotid gland. In 2011, 
Bauer et al. (3) reviewed the literature on 21 cases and 
reported an additional lesion. In 2012, two additional ca-
ses were published (4, 5). Thus, including the case here 
in described, only 25 cases have been reported to date. 
Initially, it was incorrectly believed that the lesion was 
of mesothelial origin (6). Subsequently, immunohisto-
chemical and ultrastructural studies showed that SFT is 
most likely derived from adult mesenchymal stem cells 
(7). In the parotid gland, the tumor presumably origina-
tes from mesenchymal cells of the parenchyma (8).
Our patient was a 42-year-old male and reported first 
noticing the lesion two months before. This is in accor-
dance with the literature, which indicates a slight male 
predominance (1.2:1 F:M ratio) and a mean age of 49.8 
years. However, it is important to note that SFT affects 
patients of all ages, ranging from 11 to 79 years. SFT 
is more common on the left parotid gland, as seen in 
our case. Of the 22 reported cases which specified the 
side of the lesion, 14 were in the left side, while 8 were 
in the right side (1.75:1 ratio). The lesion grows slowly 
and may achieve significant sizes. Based on review of 25 
cases, duration of symptoms ranged from 4 to 120 mon-
ths. The mean size on diagnosis was 4.4 cm, with some 
reported cases reaching 12 cm (range 1 – 12 cm). Clini-
cally, parotid SFT may mimic a variety of diseases and 
the differential diagnosis includes conditions that cause 
unilateral parotid enlargement, such as salivary gland tu-
mors, mesenchymal neoplasms, lymphomas, Sjogren’s 
syndrome, sarcoidosis, sialadenosis and infections (3-5). 
Table 1 summarizes the demographic and clinical infor-
mation of all previously published cases of parotid SFT, 
including the case here in described.
Feature* Number
Age range (years) 11-79
     Mean age 49.8
Gender
     Male 14
     Female 11
     M:F ratio 1.2
Size range (cm) 1-12
     Mean size 4.4
Location
     Left 14
     Right 8
Duration range (months) 4-120 
     Mean duration 23.7
*Adapted from Bauer et al. (3). Data was unavailable in some cases.
Table 1. Demographic, clinical and immunohistochemical profile of 
25 reported SFT cases.
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are more likely to behave aggressively. In general, more 
than six mitoses per 10 high-power fields suggest a ma-
lignant tumor. However, it should be noted that histolo-
gic features do not reliably predict aggressive clinical 
behavior (9,12,13). Immunohistochemically, malignant 
SFT tends to show reduced CD34 reactivity when com-
pared to benign tumors (9). Regarding treatment, there is 
currently no evidence that malignant SFTs require addi-
tional treatment beyond excision, as long as the lesion is 
completely excised (14,15). 
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